Total Payments
$8,591
2023 Payments
$331.24
Companies
36
Transactions
391
Medicare Patients
704
Medicare Billing
$64,806
Payment Breakdown by Category
Food & Beverage$7,918 (92.2%)
Education$449.34 (5.2%)
Other$210.30 (2.4%)
Travel$13.33 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,918 | 373 | 92.2% |
| Education | $449.34 | 7 | 5.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $210.30 | 10 | 2.4% |
| Travel and Lodging | $13.33 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $902.60 | 29 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $815.91 | 47 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $786.24 | 46 | $0 (2020) |
| Genentech USA, Inc. | $633.39 | 20 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $483.33 | 6 | $0 (2023) |
| UCB, Inc. | $480.43 | 19 | $0 (2023) |
| EMD Serono, Inc. | $443.07 | 21 | $0 (2020) |
| Jazz Pharmaceuticals Inc. | $433.80 | 14 | $0 (2020) |
| ACADIA Pharmaceuticals Inc | $420.31 | 32 | $0 (2021) |
| Allergan, Inc. | $317.29 | 19 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $331.24 | 4 | Alexion Pharmaceuticals, Inc. ($193.50) |
| 2022 | $125.00 | 1 | Alexion Pharmaceuticals, Inc. ($125.00) |
| 2021 | $120.88 | 8 | ACADIA Pharmaceuticals Inc ($67.39) |
| 2020 | $1,748 | 92 | GENZYME CORPORATION ($149.53) |
| 2019 | $2,516 | 136 | Novartis Pharmaceuticals Corporation ($474.19) |
| 2018 | $1,570 | 60 | Teva Pharmaceuticals USA, Inc. ($354.17) |
| 2017 | $2,179 | 90 | GENZYME CORPORATION ($420.08) |
All Payment Transactions
391 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/16/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $124.41 | General |
| 11/16/2023 | UCB, Inc. | — | Travel and Lodging | In-kind items and services | $13.33 | General |
| 08/24/2023 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $124.98 | General |
| 07/25/2023 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $68.52 | General |
| Category: Rare Disease | ||||||
| 08/18/2022 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Rare Disease | ||||||
| 04/28/2021 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 04/20/2021 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 03/16/2021 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 03/10/2021 | GE HEALTHCARE | — | Food and Beverage | Cash or cash equivalent | $17.32 | General |
| 03/02/2021 | Adamas Pharmaceuticals, Inc. | GOCOVRI (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: PD | ||||||
| 02/19/2021 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 02/03/2021 | Adamas Pharmaceuticals, Inc. | GOCOVRI (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: PD | ||||||
| 01/26/2021 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/18/2020 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), ONGENTYS | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: NEUROLOGY | ||||||
| 12/15/2020 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $23.71 | General |
| Category: PARKINSONS DISEASE | ||||||
| 12/15/2020 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/09/2020 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $16.68 | General |
| 12/09/2020 | Janssen Pharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $10.49 | General |
| 12/07/2020 | GENZYME CORPORATION | LEMTRADA (Biological) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Neurology | ||||||
| 12/03/2020 | Adamas Pharmaceuticals, Inc. | GOCOVRI (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: PD | ||||||
| 12/02/2020 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $8.24 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2020 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/30/2020 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: NEUROLOGY | ||||||
| 11/24/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/20/2020 | Genentech, Inc. | Activase (Biological) | Education | In-kind items and services | $47.95 | General |
| Category: Metabolism & Primary Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 300 | 365 | $112,229 | $29,293 |
| 2022 | 3 | 55 | 63 | $22,633 | $6,138 |
| 2020 | 8 | 349 | 430 | $100,626 | $29,376 |
Total Patients
704
Total Services
858
Medicare Billing
$64,806
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 78 | 78 | $46,410 | $13,855 | 29.9% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 64 | 86 | $21,758 | $4,816 | 22.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 34 | $10,608 | $3,680 | 34.7% |
| 92250 | Photography of the retina | Office | 2023 | 58 | 73 | $16,060 | $2,417 | 15.0% |
| 92133 | Imaging of optic nerve | Office | 2023 | 59 | 79 | $10,823 | $2,363 | 21.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 15 | $6,570 | $2,163 | 32.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 25 | 25 | $14,875 | $4,396 | 29.6% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 17 | 22 | $5,566 | $1,259 | 22.6% |
| 92133 | Imaging of optic nerve | Office | 2022 | 13 | 16 | $2,192 | $482.40 | 22.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 140 | 197 | $53,781 | $15,542 | 28.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 26 | 26 | $13,676 | $4,044 | 29.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 32 | 33 | $12,111 | $3,859 | 31.9% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 35 | 47 | $7,285 | $1,936 | 26.6% |
| 92540 | Observation, testing, and recording of abnormal eye movement | Office | 2020 | 27 | 27 | $5,454 | $1,733 | 31.8% |
| 92250 | Photography of the retina | Office | 2020 | 35 | 46 | $5,106 | $1,246 | 24.4% |
| 92537 | Assessment and recording of balance system during hot and cold irrigation of both ears | Office | 2020 | 27 | 27 | $2,160 | $686.94 | 31.8% |
| 92546 | Assessment and recording of abnormal eye movement with patient in a rotating chair | Office | 2020 | 27 | 27 | $1,053 | $330.16 | 31.4% |
About Dr. Stuart Sinoff, MD
Dr. Stuart Sinoff, MD is a Neurology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659488989.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Sinoff, MD has received a total of $8,591 in payments from pharmaceutical and medical device companies, with $331.24 received in 2023. These payments were reported across 391 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($7,918).
As a Medicare-enrolled provider, Sinoff has provided services to 704 Medicare beneficiaries, totaling 858 services with total Medicare billing of $64,806. Data is available for 3 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neuro-ophthalmology
- Location Seattle, WA
- Active Since 08/24/2006
- Last Updated 01/28/2026
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1659488989
Products in Payments
- NUPLAZID (Drug) $420.31
- LEMTRADA (Drug) $417.30
- GILENYA (Drug) $394.18
- OCREVUS (Biological) $386.81
- Non-Covered Product (Drug) $316.20
- Rebif (Biological) $298.14
- AUBAGIO (Drug) $292.97
- Neupro (Drug) $267.64
- INBRIJA (Drug) $226.27
- MAYZENT (Drug) $223.31
- GOCOVRI (Drug) $218.96
- Xyrem (Drug) $217.02
- SOLIRIS (Biological) $193.52
- AJOVY (Drug) $166.02
- AUSTEDO (Drug) $165.37
- COPAXONE (Drug) $153.77
- INGREZZA (Drug) $153.38
- Duopa (Drug) $151.35
- AIMOVIG (Biological) $146.00
- NUEDEXTA (Drug) $144.49
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Seattle
Dr. Pavle Repovic, Md, Phd, MD, PHD
Neurology — Payments: $1.2M
Neurology $1.2M
Nathaniel Watson, Md, MD
Neurology — Payments: $352,101
Neurology $352,101
Mariko Kita, Md, MD
Neurology — Payments: $243,050
Neurology $243,050
Kyra Becker
Neurology — Payments: $239,174
Neurology $239,174
Christyn Edmundson, Md, MD
Neurology — Payments: $226,530
Neurology $226,530
Pravin Khemani, Md, MD
Neurology — Payments: $199,884
Neurology $199,884